Search results
Results From The WOW.Com Content Network
The 4Kscore® Test is a non-invasive blood test that assesses a patient’s probability for aggressive prostate cancer after an abnormal PSA or DRE result.
The 4Kscore® Test is an FDA-approved blood test developed to improve patient care by providing a man’s probability for aggressive prostate cancer after an abnormal PSA or other screening result and prior to making a shared decision. The 4Kscore® Test provides physicians and patients with highly accurate, actionable information to make ...
The 4Kscore® Test is a simple blood test that combines four prostate-specific biomarkers along with patient clinical information in a complex algorithm that determines the probability of aggressive prostate cancer if a biopsy were to be performed.
The 4Kscore® Test is a follow-up blood test after an abnormal PSA and/or digital rectal exam (DRE) to assess your probability of finding aggressive prostate cancer, using four prostate-specific biomarkers and your clinical information.
The 4Kscore® Test is a follow-up blood test after an abnormal PSA (Prostate Specific Antigen) or digital rectal exam (DRE) to provide the probability of finding aggressive prostate cancer if a biopsy were to be performed.
The 4Kscore® Test Helps Clarify the Biopsy Decision-Making Process by Determining a Patient-Specific Probability for Finding Aggressive Prostate Cancer on Biopsy.
The 4Kscore® requires a test order form from your physician. You can find a Patient Service Center by using the link below. Find a 4Kscore® physician or a 4Kscore test collection center near you. Call us if you need additional assistance at 1-833-4Kscore.
Find The 4Kscore® Test Near You. You can find a Patient Service Center by using the link below.
For more information about The 4Kscore® Test, please call us at 833-4KSCORE (833-457-2673). For questions about insurance coverage and cost, please call our dedicated hotline at 855-4KBILLING ( 855-452-4554 ).
The 4Kscore® Test is covered by most leading healthcare insurance plans. We will bill a patient’s insurance company, and the patient will only be responsible for applicable copayment, co-insurance, and/or deductible amounts.